BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6407071)

  • 1. Choleretic effect of structural analogs of valproic acid in the rat.
    Watkins JB; Klaassen CD
    Res Commun Chem Pathol Pharmacol; 1983 Mar; 39(3):355-66. PubMed ID: 6407071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of inducers and inhibitors of glucuronidation on the biliary excretion and choleretic action of valproic acid in the rat.
    Watkins JB; Klaassen CD
    J Pharmacol Exp Ther; 1982 Feb; 220(2):305-10. PubMed ID: 6799642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choleretic and diuretic properties of dihydroxydibutyl ether in the rat.
    Corbic M; Dumont M; De Couët G; Erlinger S
    J Pharmacol Exp Ther; 1982 Jun; 221(3):769-74. PubMed ID: 7086686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choleretic effect of valproic acid in the rat.
    Watkins JB; Klaassen CD
    Hepatology; 1981; 1(4):341-7. PubMed ID: 6793496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Choleretic mechanism and effects of cyclobutyrol in the rat: dose-response relationship.
    Monte MJ; Aybar R; Cava F; Esteller A; Jimenez R
    Biomed Biochim Acta; 1990; 49(1):83-90. PubMed ID: 2360911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An osmotic explanation for valproic acid induced choleresis in the rat, dog and monkey.
    Dickinson RG; Harland RC; Kaufman SN; Lynn RK; Gerber N
    Arzneimittelforschung; 1982; 32(3):241-7. PubMed ID: 6805484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Choleretic activity of 3-[ring substituted benzotriazol-1(2)-yl]alkanoic and alkenoic acids.
    Paglietti G; Sanna P; Carta A; Sparatore F; Vazzana I; Peana A; Satta M
    Farmaco; 1994 Nov; 40(11):693-702. PubMed ID: 7832971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescent bile acid derivatives: relationship between chemical structure and hepatic and intestinal transport in the rat.
    Holzinger F; Schteingart CD; Ton-Nu HT; Eming SA; Monte MJ; Hagey LR; Hofmann AF
    Hepatology; 1997 Nov; 26(5):1263-71. PubMed ID: 9362371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of hydroxyacetophenone analogues on the transcytotic vesicular pathway in rat liver.
    Tradtrantip L; Boyer JL; Suksamrarn A; Piyachaturawat P
    Eur J Pharmacol; 2006 Oct; 547(1-3):152-9. PubMed ID: 16945364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonlinear elimination and cholerteic effect of valproic acid in the monkey.
    Dickinson RG; Taylor SM; Kaufman SN; Rodgers RM; Lynn RK; Gerber N; Baughman WL
    J Pharmacol Exp Ther; 1980 Apr; 213(1):38-48. PubMed ID: 6767022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of valproate analogs in rats. III. Pharmacokinetics of valproic acid, cyclohexanecarboxylic acid, and 1-methyl-1-cyclohexanecarboxylic acid in the bile-exteriorized rat.
    Liu MJ; Brouwer KL; Pollack GM
    Drug Metab Dispos; 1992; 20(6):810-5. PubMed ID: 1362931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further branching of valproate-related carboxylic acids reduces the teratogenic activity, but not the anticonvulsant effect.
    Bojic U; Elmazar MM; Hauck RS; Nau H
    Chem Res Toxicol; 1996; 9(5):866-70. PubMed ID: 8828922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibition by dipropyl acetate and its structural analogs of the glycine synthase system in liver and brain mitochondria].
    Martín A; Benavides J; Ugarte M
    Rev Esp Fisiol; 1982; 38 Suppl():59-62. PubMed ID: 6815738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible impairment of neonatal hepatobiliary function by maternal cholestasis.
    Monte MJ; Morales AI; Arevalo M; Alvaro I; Macias RI; Marin JJ
    Hepatology; 1996 May; 23(5):1208-17. PubMed ID: 8621155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Choleretic action of ethacrynic acid in the rat].
    Campese VM; Siro-Brigiani G
    Boll Soc Ital Biol Sper; 1971 Jan; 47(1):22-3. PubMed ID: 5088813
    [No Abstract]   [Full Text] [Related]  

  • 16. Structure-activity studies of 6-(tetrazolylalkyl)-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 1. Effects of stereochemistry, chain length, and chain substitution.
    Ornstein PL; Arnold MB; Allen NK; Bleisch T; Borromeo PS; Lugar CW; Leander JD; Lodge D; Schoepp DD
    J Med Chem; 1996 May; 39(11):2219-31. PubMed ID: 8667365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new choleretic effect of folinic acid.
    Kajiyama Y; Tsurumaru M; Udagawa H; Tsutsumi K; Kinoshita Y; Ueno M; Akiyama H
    Hepatogastroenterology; 1998; 45(23):1442-5. PubMed ID: 9840080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biliary excretion and choleretic effect of cefmetazole in rats.
    Gonzalez J; Fernandez C; Marińo E; Morales A; Jimenez R
    Antimicrob Agents Chemother; 1989 Nov; 33(11):1970-4. PubMed ID: 2610507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and choleretic activity of 3-[2-(3-R', 4-R'', 5-R'''-benzyl)-5-R-benzimidazol-1-yl]-butanoic acids.
    Grella G; Paglietti G; Sparatore F; Satta M; Manca P; Peana A
    Farmaco; 1992 Jan; 47(1):21-35. PubMed ID: 1616574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.